Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Assessment of Efficacy and Tolerability of Methylphenidate vs. Risperidone in the Treatment of Children and Adolescents With ADHD and Disruptive Disorders

NCT02063945 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT02063945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02063945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Assessment of Efficacy and Tolerability of Methylphenidate vs. Risperidone in the Treatment of Children and Adolescents With ADHD and Disruptive Disorders
Lead sponsor
Sheba Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
February 1, 2017
Completion date
February 1, 2018
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit/hyperactivity disorder, conduct disorder, oppositional defiant disorder